Clinical Study
Effectiveness and Safety of Concurrent Use of First-Line Antiretroviral and Antituberculous Drugs in Rwanda
Figure 2
Cumulative percentages of the measured indicators in HIV-alone and TB/HIV groups. The difference is statistically significant ().